Fibromyalgia: The Neural Network Perspective

You hurt everywhere. The pain moves, shifts, worsens unpredictably. Tests come back normal. Imaging shows nothing. Blood work is unremarkable. And yet the pain is real — crushing, exhausting, and completely resistant to conventional treatment.

Fibromyalgia is one of the most contested diagnoses in medicine. But the debate about whether it is “real” misses the point entirely. The question is not whether the pain exists — it does, measurably and undeniably. The question is: what mechanism is generating it?

Central Sensitization: The Brain Amplifying Pain

Current research has established that fibromyalgia is a disorder of central sensitization — the central nervous system amplifies pain signals, producing the experience of widespread pain from stimuli that would not normally be painful. Research published in Nature Neuroscience has documented that prefrontal engrams of long-term fear memory can perpetuate pain perception through neural mechanisms^[1] — meaning that fear memories physically stored in the brain can sustain and amplify chronic pain.

This is not a metaphorical connection. The prefrontal cortex, amygdala, and hippocampus — the same structures that encode fear memories — are directly involved in pain processing and modulation. When a pathological neural network fires, it does not limit its output to emotions. It sends signals through the autonomic nervous system that alter how the spinal cord and brain process incoming sensory information^[2], effectively turning up the volume on pain signals.

The Fear-Pain Connection: How Neural Networks Sustain Fibromyalgia

Research has documented a specific bidirectional relationship between fear and pain^[1]. Fear memories stored as prefrontal engrams perpetuate pain perception. Pain, in turn, activates fear networks (because pain is inherently threatening). This creates a self-reinforcing loop: fear amplifies pain, pain activates fear, which amplifies pain further.

In fibromyalgia, this loop is chronic and systemic. The pathological neural network does not produce pain in one location — it alters central processing in a way that amplifies pain signals from the entire body. This explains the characteristic “wandering” quality of fibromyalgia pain: the generator is central (in the brain), not peripheral (in the tissues), so it can produce pain anywhere the CNS directs its amplified signals.

The HPA axis contributes by maintaining chronic cortisol elevation^[3], which produces systemic inflammation through pro-inflammatory cytokines (IL-1, IL-6, TNF-alpha). This inflammation sensitizes peripheral nerve endings, creating additional pain input that feeds back into the central sensitization loop. Research has shown that psychosomatic disorders involve complex interactions between the CNS, the autonomic nervous system, and peripheral tissues^[2].

Why Conventional Fibromyalgia Treatment Hits a Ceiling

The standard treatment protocol for fibromyalgia includes: antidepressants (duloxetine, milnacipran) targeting serotonin-norepinephrine pathways; anticonvulsants (pregabalin) dampening neural excitability; low-impact exercise; cognitive behavioral therapy for pain management; sleep hygiene.

These interventions can provide meaningful symptom reduction. But they share a common structural limitation: they address the outputs of the pain-amplification system (the neurochemical imbalances, the behavioral responses, the sleep disruption) without addressing the neural network generator that drives central sensitization.

This is why fibromyalgia is characterized by flares and remissions. During lower-stress periods, the neural network’s activation may decrease, and symptoms improve. Under stress, the network reactivates, central sensitization intensifies, and the pain returns — often in different locations, as if the pain has “moved.” It has not moved. The central generator has redirected its output.

The Gut-Brain Axis in Fibromyalgia

Research has demonstrated that gut microbiota significantly influence pain processing and emotional regulation through the gut-brain axis^[4]. Patients with fibromyalgia show documented alterations in gut microbiota composition that correlate with symptom severity. Chronic stress from the pathological neural network disrupts gut microbiota, and the disrupted microbiota produce neuroactive compounds that increase pain sensitivity and emotional reactivity — another self-reinforcing loop.

The Structural Approach: Address the Generator, Not Just the Pain

The Efremov Method® approaches fibromyalgia by targeting the pathological neural network that drives central sensitization. When the fear-based network’s charge is collapsed, the chronic signal that amplifies pain processing ceases at the source. The central sensitization loses its driver.

This does not negate the value of medication, exercise, or other management strategies. But it addresses the level of the problem that these interventions cannot reach: the neural generator that sustains the pain-amplification cycle. When the generator stops, the pain-fear loop breaks, the HPA axis normalizes, inflammatory markers decrease, and the central sensitization process loses the input that maintains it.